FendX Technologies (XCNQ:FNDX) EBITDA Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is FendX Technologies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. FendX Technologies's EBITDA for the three months ended in Mar. 2024 was C$-1.07 Mil. FendX Technologies's Revenue for the three months ended in Mar. 2024 was C$0.00 Mil. Therefore, FendX Technologies's EBITDA margin for the quarter that ended in Mar. 2024 was 0.00%.

FendX Technologies EBITDA Margin % Historical Data

The historical data trend for FendX Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FendX Technologies EBITDA Margin % Chart

FendX Technologies Annual Data

Trend

Dec21

Dec22

Dec23

EBITDA Margin %

FendX Technologies Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBITDA Margin %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of FendX Technologies's EBITDA Margin %

For the Specialty Chemicals subindustry, FendX Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FendX Technologies's EBITDA Margin % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, FendX Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where FendX Technologies's EBITDA Margin % falls into.

FendX Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

FendX Technologies's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3.763	/	0
	=	%

FendX Technologies's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-1.074	/	0
	=	%

FendX Technologies (XCNQ:FNDX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

FendX Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of FendX Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

FendX Technologies (XCNQ:FNDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » FendX Technologies Inc (XCNQ:FNDX) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

FDXTF:USA E8D:Germany

Address

2010 Winston Park Drive, 2nd Floor, Oakville, ON, CAN, L6H 5R7

Website

https://www.fendxtech.com

FendX Technologies Inc is a technology company focused on developing surface protection products that protect surfaces from pathogen contamination. It is focused on the research, development and commercialization of surface protection coatings using Licensed Technology. The company is currently developing its anticipated first product, REPELWRAP to protect high-contact surfaces from contamination to reduce the transmission of harmful pathogens. The Company has a growing intellectual property portfolio consisting of licensed nonprovisional national stage patent applications.